Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000871.02
Abstract: INTRODUCTION AND OBJECTIVE:Vibegron is a novel, once-daily, oral β3-adrenoceptor agonist under development for treatment of OAB. In the phase 3, randomized, double-blind, placebo- and active-contro...
read more here.
Keywords:
overactive bladder;
efficacy daily;
pd21 efficacy;
daily vibegron ... See more keywords